News
Panaxia Israel continues growth trend in the first quarter of 2021: reports record revenues of 19.7 million
May 31, 2021
May 31 2021 | Yahoo! 62% growth over the corresponding period the previous year and 16% over the previous quarter; The company is currently focused on
Panaxia and Leriva announced: Exclusive collaborations in Greece
May 20, 2021
May 19 2021 | Yahoo! Following a successful launch at the local markets in Germany, France, and Cyprus, Panaxia’s medical cannabis-based products will be distributed in
Panaxia sells Israeli cannabis pharmacy to focus on exports
May 6, 2021
May 3 2021 | Globes Panaxia Israel is selling its pharmacy, one of Israel’s largest for cannabis products, to IMC for NIS 20 million. Six months
Panaxia Israel announces estimated record revenues of at least 19 million in Q1 2021
April 18, 2021
April 12, 2021 | Market Watch LOD, Israel, April 12, 2021 /PRNewswire/ — The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. (“Panaxia Israel”) (TASE: PNAX), Israel’s largest manufacturer of